湖北地区妊娠合并新型冠状病毒肺炎的妊娠结局分析
该回顾性研究比较了16例妊娠合并COVID-19孕妇与45例未合并COVID-19孕妇的妊娠结局,并分析了10例COVID-19孕妇分娩新生儿的实验室和核酸检测结果。研究发现两组分娩方式均为剖宫产,分娩孕周、术中出血量及新生儿出生体重无显著差异;10例新生儿核酸检测均阴性,未发现感染。COVID-19孕妇剖宫产术中因宫缩乏力使用卡贝缩宫素或卡前列素氨丁三醇的量显著多于对照组。
要点
- 有产科手术指征或COVID-19病情危重时,适时终止妊娠不增加早产和新生儿窒息风险。
- COVID-19孕妇剖宫产术中预防性使用长效宫缩剂可减少产后出血。
- 妊娠合并COVID-19分娩的新生儿未发现新型冠状病毒感染。
核心结论
- 有产科手术指征或COVID-19病情危重时,适时终止妊娠不增加早产和新生儿窒息风险,且有利于产妇肺炎治疗与康复。
- 术中预防性使用长效宫缩剂可减少产后出血发生。
- 妊娠合并COVID-19分娩的新生儿未发现新型冠状病毒感染。
研究设计与样本
- 回顾性对比16例妊娠合并COVID-19孕妇与45例未合并COVID-19孕妇的妊娠结局。
- 对10例COVID-19孕妇分娩新生儿的实验室检查、影像学检查及新型冠状病毒核酸检测结果进行分析。
主要发现
- 16例COVID-19孕妇中普通型15例、重型1例,无进展为危重型肺炎者。
- 两组分娩方式均为剖宫产,分娩孕周分别为(38.7±1.4)周和(37.9±1.6)周,差异无统计学意义(P>0.05)。
- 两组剖宫产术中出血量及新生儿出生体重比较,差异均无统计学意义(P均>0.05)。
- 10例COVID-19孕妇分娩的新生儿核酸检测均阴性,两组胎儿窘迫、羊水粪染、早产、新生儿窒息比较差异均无统计学意义(P均>0.05)。
- COVID-19孕妇剖宫产术中因宫缩乏力使用卡贝缩宫素或卡前列素氨丁三醇(1.3±0.6)支,多于未合并COVID-19孕妇的(0.5±0.7)支,差异有统计学意义(P=0.001)。
关键数值与推荐
- COVID-19孕妇剖宫产术中因子宫收缩乏力使用卡贝缩宫素或卡前列素氨丁三醇(1.3±0.6)支,未合并COVID-19孕妇为(0.5±0.7)支,P=0.001。
临床怎么用
- 对有产科手术指征或COVID-19病情危重的孕妇,应及时终止妊娠,不增加早产和新生儿窒息风险。
- 剖宫产术中可预防性使用长效宫缩剂以减少产后出血。
- COVID-19孕妇分娩的新生儿未发现感染,但需继续观察。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the effect of COVID-19 on pregnancy outcomes and neonatal prognosis in Hubei Province. Method: s A retrospective comparison of the pregnancy outcomes was done between 16 women with COVID-19 and 45 women without COVID-19. Also, the results of laboratory tests, imaging examinations, and the 2019 novel coronavirus (2019-nCoV) nucleic acid test were performed in 10 cases of neonatal delivered from women with COVID-19. Result: s (1) Of the 16 pregnant women with COVID-19, 15 cases were ordinary type and 1 case was severe type. No one has progressed to critical pneumonia.The delivery method of the two groups was cesarean section, and the gestational age were (38.7±1.4) and (37.9±1.6) weeks,there was no significant difference between the two groups (P>0.05). Also, there wee no significant differences in the intraoperative blood loss and birth weight of the newborn between the two groups (all P>0.05). (2) Ten cases of neonates delivered from pregnant women with COVID-19 were collected. The 2019-nCoV nucleic acid test were all negative.There were no significant differences in fetal distress, meconium-stained amniotic fluid, preterm birth, and neonatal asphyxia between the two groups (all P>0.05).(3) In the treatment of uterine contraction fatigue, carbetocin or carboprost tromethamine was used more in cesarean section for pregnant women with COVID-19 (1.3±0.6), compared with Non-COVID-19 group (0.5±0.7),the difference was statistically significant (P=0.001). Conclusions: If there is an indication for obstetric surgery or critical illness of COVID-19 in pregnant women, timely termination of pregnancy will not increase the risk of premature birth and asphyxia of the newborn, but it is beneficial to the treatment and rehabilitation of maternal pneumonia. Preventive use of long-acting uterotonic agents could reduce the incidence of postpartum hemorrhage during surgery. 2019-nCoV infection has not been found in neonates delivered from pregnant women with COVID-19. 目的: 研究湖北地区新型冠状病毒感染对孕妇的妊娠结局及新生儿预后的影响。 方法: 回顾性对比16例妊娠合并新型冠状病毒肺炎孕妇与45例未合并新型冠状病毒肺炎孕妇的妊娠结局,同时对临床资料完整的10例新型冠状病毒肺炎孕妇分娩的新生儿实验室检查、影像学检查及新型冠状病毒核酸检查结果进行分析。 结果: (1)16例新型冠状病毒肺炎孕妇中普通型15例、重型1例,目前尚无一例进展为危重型肺炎。两组孕妇的分娩方式均为剖宫产术分娩,分娩孕周分别为(38.7±1.4)周、(37.9±1.6)周,两组比较,差异无统计学意义(P>0.05)。两组孕妇剖宫产术中出血量、新生儿出生体重分别比较,差异均无统计学意义(P均>0.05)。(2)收集到的10例新型冠状病毒肺炎感染孕妇分娩的新生儿均未感染新型冠状病毒。两组在胎儿窘迫、羊水粪染、早产、新生儿窒息方面分别比较,差异均无统计学意义(P均>0.05)。(3)新型冠状病毒肺炎感染孕妇剖宫产术中因子宫收缩乏力使用卡贝缩宫素或卡前列素氨丁三醇[(1.3±0.6)支]多于未合并新型冠状病毒肺炎的孕妇[(0.5±0.7)支],两者比较,差异有统计学意义(P=0.001)。 结论: 有产科手术指征或孕妇新型冠状病毒肺炎病情危重的情况下,适时终止妊娠不会增加新生儿窒息及早产的风险,但有利于产妇肺炎病情的治疗及康复;术中预防性使用长效宫缩剂可减少产后出血的发生。妊娠合并新型冠状病毒肺炎分娩的新生儿未发现新型冠状病毒感染。.
引用
- Zhang L, Jiang Y, Wei M, et al. [Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province]. Zhonghua Fu Chan Ke Za Zhi. 2020. PMID: 32145714. doi:10.3760/cma.j.cn112141-20200218-00111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。